Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
4.0 Future therapeutic opportunities in neurodegenerative diseases Recent clinical and preclinical evidence has established the potential of incretin mimetics to target pathological features central to neurodegenerative disorders
Key Features Next-generation investigational peptide with triple receptor agonist activity Interacts with GLP-1, GIP, and glucagon receptor pathways in research models Manufactured under controlled conditions with batch-level quality control Supplied as a lyophilized powder for enhanced stability and storage Applications Metabolic pathway and receptor signaling research Experimental studies related to obesity and metabolic disorders Research involving glucose regulation and lipid metabolism mechanisms Advanced laboratory investigation of multi-receptor peptide activity All applications are strictly limited to laboratory research use only
In a study conducted by Ng et
Other rare side effects include pancreatitis, gallbladder issues, low blood sugar and kidney problems
[PDF] nature.com Chen, Junjie, et al
US$ 21.69
US$ 20.93
US$ 21.58
US$ 28.84
US$ 28.72
